Amgen (AMGN) Assets (2016 - 2026)

Amgen has reported Assets over the past 18 years, most recently at $92.5 billion for Q1 2026.

For Q1 2026, Assets rose 3.51% year-over-year to $92.5 billion; the TTM value through Mar 2026 reached $92.5 billion, up 3.51%, while the annual FY2025 figure was $90.6 billion, 1.36% down from the prior year.
Assets for Q1 2026 was $92.5 billion at Amgen, up from $90.6 billion in the prior quarter.
Over five years, Assets peaked at $97.2 billion in Q4 2023 and troughed at $59.2 billion in Q1 2022.
A 5-year average of $84.2 billion and a median of $90.3 billion in 2023 define the central range for Assets.
Biggest five-year swings in Assets: soared 52.24% in 2023 and later fell 5.47% in 2024.
Year by year, Assets stood at $65.1 billion in 2022, then skyrocketed by 49.19% to $97.2 billion in 2023, then dropped by 5.47% to $91.8 billion in 2024, then decreased by 1.36% to $90.6 billion in 2025, then grew by 2.12% to $92.5 billion in 2026.
Business Quant data shows Assets for AMGN at $92.5 billion in Q1 2026, $90.6 billion in Q4 2025, and $90.1 billion in Q3 2025.

Peer Comparison